×

India to Celebrate World Tuberculosis Day 2026 with Major Initiatives

On March 24, 2026, India will commemorate World Tuberculosis Day with a national event at Gautam Buddha University. The gathering will showcase the country's achievements and innovative strategies under the National Tuberculosis Elimination Programme. Union Health Minister JP Nadda will launch key initiatives aimed at enhancing TB case detection and treatment adherence. This event aligns with the theme 'Yes! We Can End TB!' and reflects India's commitment to intensifying efforts against tuberculosis. The government emphasizes the effectiveness of shorter treatment regimens for multidrug-resistant TB, promising better health outcomes at lower costs. This event will bring together various stakeholders to reinforce collaborative efforts in the fight against TB.
 

National Event to Mark World TB Day


New Delhi, March 23: The Indian government is preparing to observe World Tuberculosis (TB) Day 2026 with a significant national event scheduled for March 24. This gathering aims to highlight notable achievements, innovative approaches, and enhanced community involvement under the National Tuberculosis Elimination Programme (NTEP), as stated in an official announcement on Monday.


The event will take place at Gautam Buddha University located in Greater Noida, Uttar Pradesh, and will emphasize India’s swift advancements towards eradicating TB, aligning with Prime Minister Narendra Modi’s vision of a TB-free India, according to the Ministry of Health and Family Welfare.


Union Health Minister JP Nadda is expected to inaugurate the 'TB Mukt Bharat Abhiyaan – 100 Days Campaign' and introduce the TB Mukt Bharat App along with the TB Mukt Urban Ward Initiative.


These initiatives are designed to enhance case detection, ensure better treatment adherence, and improve the delivery of TB services, particularly in regions with high TB burdens, the statement noted.


"These initiatives align with the theme of World TB Day 2026 — 'Yes! We Can End TB!' and demonstrate India’s renewed dedication to intensifying the battle against TB," the statement added.


The event will gather ministers, senior officials from both Union and State governments, public health experts, development partners, healthcare professionals, and community representatives.


This occasion will reaffirm the nation’s commitment to enhancing multi-sectoral collaboration and implementing evidence-based strategies for TB elimination.


Recently, the government highlighted that shorter, six-month all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) are not only cost-effective but also yield better health outcomes compared to longer treatment courses.


According to a study by the ICMR, the Ministry of Health and Family Welfare reported that with the shorter regimen, "for each additional Quality Adjusted Life Year (QALY) gained, the health system spends Rs 379 less per patient compared to the standard regimen, indicating improved health outcomes at reduced costs."